Brian Abrahams
Stock Analyst at RBC Capital
(2.35)
# 2,362
Out of 5,182 analysts
455
Total ratings
41.96%
Success rate
-0.41%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMRA Damora Therapeutics | Initiates: Outperform | $40 | $24.75 | +61.62% | 1 | Apr 24, 2026 | |
| EVMN Evommune | Reiterates: Outperform | $48 | $25.38 | +89.13% | 1 | Apr 10, 2026 | |
| PHVS Pharvaris | Maintains: Outperform | $52 → $51 | $28.58 | +78.45% | 2 | Apr 6, 2026 | |
| APGE Apogee Therapeutics | Maintains: Sector Perform | $83 → $82 | $85.61 | -4.22% | 4 | Mar 3, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Sector Perform | $745 → $765 | $751.57 | +1.79% | 36 | Mar 2, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Sector Perform | $12 → $13 | $17.18 | -24.33% | 5 | Mar 2, 2026 | |
| AARD Aardvark Therapeutics | Downgrades: Sector Perform | $18 → $6 | $5.39 | +11.32% | 6 | Mar 2, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Outperform | $31 → $30 | $21.96 | +36.61% | 5 | Feb 26, 2026 | |
| GLPG Galapagos NV | Maintains: Sector Perform | $32 → $33 | $28.64 | +15.22% | 14 | Feb 25, 2026 | |
| PRTA Prothena Corporation | Maintains: Sector Perform | $11 → $12 | $10.75 | +11.63% | 13 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $87 → $82 | $68.23 | +20.18% | 24 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $546 → $541 | $430.29 | +25.73% | 58 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $180 → $177 | $127.68 | +38.63% | 25 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $95 → $92 | $94.65 | -2.80% | 25 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $103 → $118 | $130.40 | -9.51% | 35 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $217 → $233 | $184.38 | +26.37% | 42 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $13 | $8.94 | +45.41% | 20 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $30 | $16.68 | +79.86% | 1 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $40 | $20.25 | +97.53% | 2 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $36 | $22.48 | +60.14% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $103 | $84.91 | +21.30% | 2 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $38.11 | -37.02% | 2 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $4 → $7 | $2.25 | +211.11% | 7 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $22 | $12.41 | +77.28% | 6 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $53 | $10.06 | +426.84% | 9 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $1.5 → $1 | $0.79 | +27.37% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $3 → $2 | $1.24 | +61.29% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $58 | $55.24 | +5.00% | 20 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $19 | $8.66 | +119.40% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $20.30 | +13.30% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $23.90 | +251.46% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $185.96 | -23.10% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $29.72 | +34.59% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $13.31 | +12.70% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $4.63 | +94.38% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $24.10 | - | 4 | Dec 4, 2017 |
Damora Therapeutics
Apr 24, 2026
Initiates: Outperform
Price Target: $40
Current: $24.75
Upside: +61.62%
Evommune
Apr 10, 2026
Reiterates: Outperform
Price Target: $48
Current: $25.38
Upside: +89.13%
Pharvaris
Apr 6, 2026
Maintains: Outperform
Price Target: $52 → $51
Current: $28.58
Upside: +78.45%
Apogee Therapeutics
Mar 3, 2026
Maintains: Sector Perform
Price Target: $83 → $82
Current: $85.61
Upside: -4.22%
Regeneron Pharmaceuticals
Mar 2, 2026
Maintains: Sector Perform
Price Target: $745 → $765
Current: $751.57
Upside: +1.79%
MoonLake Immunotherapeutics
Mar 2, 2026
Maintains: Sector Perform
Price Target: $12 → $13
Current: $17.18
Upside: -24.33%
Aardvark Therapeutics
Mar 2, 2026
Downgrades: Sector Perform
Price Target: $18 → $6
Current: $5.39
Upside: +11.32%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Outperform
Price Target: $31 → $30
Current: $21.96
Upside: +36.61%
Galapagos NV
Feb 25, 2026
Maintains: Sector Perform
Price Target: $32 → $33
Current: $28.64
Upside: +15.22%
Prothena Corporation
Feb 20, 2026
Maintains: Sector Perform
Price Target: $11 → $12
Current: $10.75
Upside: +11.63%
Feb 20, 2026
Maintains: Sector Perform
Price Target: $87 → $82
Current: $68.23
Upside: +20.18%
Feb 13, 2026
Maintains: Outperform
Price Target: $546 → $541
Current: $430.29
Upside: +25.73%
Feb 12, 2026
Maintains: Outperform
Price Target: $180 → $177
Current: $127.68
Upside: +38.63%
Feb 11, 2026
Maintains: Sector Perform
Price Target: $95 → $92
Current: $94.65
Upside: -2.80%
Feb 11, 2026
Maintains: Sector Perform
Price Target: $103 → $118
Current: $130.40
Upside: -9.51%
Feb 9, 2026
Maintains: Outperform
Price Target: $217 → $233
Current: $184.38
Upside: +26.37%
Jan 30, 2026
Maintains: Outperform
Price Target: $14 → $13
Current: $8.94
Upside: +45.41%
Jan 29, 2026
Maintains: Outperform
Price Target: $28 → $30
Current: $16.68
Upside: +79.86%
Jan 23, 2026
Maintains: Outperform
Price Target: $33 → $40
Current: $20.25
Upside: +97.53%
Jan 23, 2026
Maintains: Outperform
Price Target: $20 → $36
Current: $22.48
Upside: +60.14%
Dec 16, 2025
Maintains: Outperform
Price Target: $70 → $103
Current: $84.91
Upside: +21.30%
Dec 1, 2025
Downgrades: Underperform
Price Target: $24
Current: $38.11
Upside: -37.02%
Dec 1, 2025
Upgrades: Outperform
Price Target: $4 → $7
Current: $2.25
Upside: +211.11%
Nov 21, 2025
Maintains: Outperform
Price Target: $25 → $22
Current: $12.41
Upside: +77.28%
Nov 13, 2025
Maintains: Outperform
Price Target: $55 → $53
Current: $10.06
Upside: +426.84%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $1.5 → $1
Current: $0.79
Upside: +27.37%
Nov 7, 2025
Maintains: Sector Perform
Price Target: $3 → $2
Current: $1.24
Upside: +61.29%
Nov 4, 2025
Maintains: Outperform
Price Target: $55 → $58
Current: $55.24
Upside: +5.00%
Nov 4, 2025
Maintains: Outperform
Price Target: $30 → $19
Current: $8.66
Upside: +119.40%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $20.30
Upside: +13.30%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $23.90
Upside: +251.46%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $185.96
Upside: -23.10%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $29.72
Upside: +34.59%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $13.31
Upside: +12.70%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $4.63
Upside: +94.38%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $24.10
Upside: -